# Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer

> **NCT01958372** · PHASE1 · COMPLETED · sponsor: **Barbara Ann Karmanos Cancer Institute** · enrollment: 11 (actual)

## Conditions studied

- Adenocarcinoma of the Lung
- Adenosquamous Cell Lung Cancer
- Bronchoalveolar Cell Lung Cancer
- Large Cell Lung Cancer
- Recurrent Non-small Cell Lung Cancer
- Squamous Cell Lung Cancer
- Stage IIIA Non-small Cell Lung Cancer
- Stage IIIB Non-small Cell Lung Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** soy isoflavones
- **DRUG:** cisplatin
- **DRUG:** etoposide
- **DRUG:** pemetrexed disodium
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT01958372
- **Lead sponsor:** Barbara Ann Karmanos Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2017-10-09
- **Final completion:** 2019-11-11
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2020-11-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01958372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01958372, "Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01958372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*